Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

Shi DD, Calvo Fernández E, Puliyappadamba VT, Lanman TA, Xiao Y, Wen Z, Minor M, Prost D, Lasica AB, Cai F, Neumann E, Gudipelly S, Clark LM, Nguyen QD, Peña S, Wansapura J, Kaphle P, Shipman T, Levitt MM, Lin MD, Tsai AC, Lee JH, Cahill DP, Rahman R, Haas-Kogan DA, Richardson TE, Tirosh I, Jain P, Tron AE, Nakhate V, Youssef G, Dehais C, Jacob J, Reardon DA, Miller JJ, Abdullah KG, Wen PY, DeBerardinis RJ, Xu L, Touat M, Peters KB, Gonzalez Castro LN, Kaelin WG Jr, Suvà ML, McBrayer SK

Open source

DOI: 10.1126/scitranslmed.aee5876
Published: 2026 Aug 5
Container: Science translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aee5876,
  title = {Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.},
  author = {Shi DD and Calvo Fernández E and Puliyappadamba VT and Lanman TA and Xiao Y and Wen Z and Minor M and Prost D and Lasica AB and Cai F and Neumann E and Gudipelly S and Clark LM and Nguyen QD and Peña S and Wansapura J and Kaphle P and Shipman T and Levitt MM and Lin MD and Tsai AC and Lee JH and Cahill DP and Rahman R and Haas-Kogan DA and Richardson TE and Tirosh I and Jain P and Tron AE and Nakhate V and Youssef G and Dehais C and Jacob J and Reardon DA and Miller JJ and Abdullah KG and Wen PY and DeBerardinis RJ and Xu L and Touat M and Peters KB and Gonzalez Castro LN and Kaelin WG Jr and Suvà ML and McBrayer SK},
  year = {2026},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.aee5876},
  url = {https://doi.org/10.1126/scitranslmed.aee5876}
}

RIS

TY  - JOUR
TI  - Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.
AU  - Shi DD
AU  - Calvo Fernández E
AU  - Puliyappadamba VT
AU  - Lanman TA
AU  - Xiao Y
AU  - Wen Z
AU  - Minor M
AU  - Prost D
AU  - Lasica AB
AU  - Cai F
AU  - Neumann E
AU  - Gudipelly S
AU  - Clark LM
AU  - Nguyen QD
AU  - Peña S
AU  - Wansapura J
AU  - Kaphle P
AU  - Shipman T
AU  - Levitt MM
AU  - Lin MD
AU  - Tsai AC
AU  - Lee JH
AU  - Cahill DP
AU  - Rahman R
AU  - Haas-Kogan DA
AU  - Richardson TE
AU  - Tirosh I
AU  - Jain P
AU  - Tron AE
AU  - Nakhate V
AU  - Youssef G
AU  - Dehais C
AU  - Jacob J
AU  - Reardon DA
AU  - Miller JJ
AU  - Abdullah KG
AU  - Wen PY
AU  - DeBerardinis RJ
AU  - Xu L
AU  - Touat M
AU  - Peters KB
AU  - Gonzalez Castro LN
AU  - Kaelin WG Jr
AU  - Suvà ML
AU  - McBrayer SK
PY  - 2026
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.aee5876
UR  - https://doi.org/10.1126/scitranslmed.aee5876
ER  -

APA

DD, S., E, C. F., VT, P., TA, L., Y, X., Z, W., M, M., D, P., AB, L., F, C., E, N., S, G., LM, C., QD, N., S, P., J, W., P, K., T, S., MM, L., MD, L., AC, T., JH, L., DP, C., R, R., DA, H., TE, R., I, T., P, J., AE, T., V, N., G, Y., C, D., J, J., DA, R., JJ, M., KG, A., PY, W., RJ, D., L, X., M, T., KB, P., LN, G. C., Jr, K. W., ML, S., & SK, M. (2026). Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.. Science translational medicine. https://doi.org/10.1126/scitranslmed.aee5876

Source records

pubmed · retrieved 2026-09-24T23:14:17.539Z